The next generation of the World Health Organization's global antiretroviral guidance

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Hirnschall, Gottfried ^a   Harries, Anthony D ^b,c   Easterbrook, Philippa J ^a   Doherty, Meg C ^a   Ball, Andrew ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Adolescents; Adults; ARV guidelines; Children; Pregnant women; WHO

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHRONIC LIVER DISEASE; DECENTRALIZATION; DRUG INDICATION; DRUG MONITORING; DRUG RESPONSE; DRUG TREATMENT FAILURE; GROUPS BY AGE; HEALTH PROGRAM; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVESTMENT; NOTE; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADOLESCENTS; ADULT; ADULTS; ARTICLE; ARV GUIDELINES; CHEMOPROPHYLAXIS; CHILD; DRUG COMBINATION; FEMALE; INFANT; MALE; METHODOLOGY; PREGNANCY; PRESCHOOL CHILD; STANDARD;

ADOLESCENTS; ADULTS; ARV GUIDELINES; CHILDREN; PREGNANT WOMEN; WHO;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84887283015     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.18757     Document Type: Note

References (33)

1. Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach. Geneva: World Health Organization; 2002 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/prev-care/ ScalingUp-E.pdf
2. Prevention of mother-to-child transmission of HIV: selection and use of nevirapine. Technical notes, 28 February 2001 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/mtct/nevirapine/en/index.html
3. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva: World Health Organization; 2004 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/mtct/en/arvdrugswomenguidelinesfinal.pdf
4. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. Geneva: World Health Organization; 2006 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
5. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2006 revision. Geneva: World Health Organization; 2006 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/mtct/antiretroviral/en/ index.html
6. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2006 revision. Geneva: World Health Organization; 2006 [cited 2013 May 17]. Available from: http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf
7. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2010 revision. Geneva: World Health Organization; 2010 [cited 2013 May 17]. Available from: http://whqlibdoc.who.int/publications/2010/ 9789241599818-eng.pdf
8. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2010 revision. Geneva: World Health Organization; 2010 [cited 2013 May 17]. Available from: http://whqlibdoc.who.int/publications/2010/9789241599801-eng.pdf
9. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. Geneva: World Health Organization; 2010 [cited 2013 May 17]. Available from: http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf
10. Gupta S, Granich R, Suthar AB, Smyth C, Baggaley R, Sculier D, et al. Global policy review of ART eligibility criteria for treatment and prevention of HIV and TB in adults, pregnant women, and serodiscordant couples: ART recommendations by national guidelines. J Acquir Immune Defic Syndr. 2013;62(3): e87-e97.
11. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Geneva: World Health Organization; 2011 [cited 2013 May 17]. Available from: http://whqlibdoc.who. int/publications/2011/9789241502986-eng.pdf
12. Global update on HIV treatment: results, impact and opportunities. Geneva: World Health Organization; 2013. [cited 2013 June 30]. Availabe from: http://www.who.int/hiv/pub/treatmentupdate2013/
13. United Nations General Assembly. Political declaration on HIV/AIDS: intensifying our efforts to eliminate HIV and AIDS-United Nations General Assembly Resolution 65/277. New York: United Nations; 2011.
14. Staveteig S,Wang S, Head SK, Bradley SEK, Nybro E. Demographic patterns of HIV testing uptake in sub-Saharan Africa. DHS Comparative Reports No 30. Calverton: ICF International; 2013.
15. Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013;10(1):e1001369.
16. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
17. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363(3):257-65.
18. When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352-63.
19. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, et al. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009;151(3):157-66.
20. Guidance on couples HIV testing and counseling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva: World Health Organization; 2012 [cited 2013 May 17]. Available from: http://whqlibdoc.who.int/publications/2012/ 9789241501972-eng.pdf
21. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: programmatic update. Geneva: World Health Organization; 2012 [cited 2013 May 17]. Available from: http://www.who.int/hiv/ pub/mtct/programmatic-update2012/en/index.html
22. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and stakeholders. Geneva: World Health Organization; 2012 [cited 2013 May 17]. Available from: http://whqlibdoc.who.int/publications/2012/ 9789241503006-eng.pdf
23. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva: World Health Organization; 2012 [cited 2013 May 15]. Available from: http://apps.who.int/iris/bitstream/10665/75188/1/9789241503884-eng.pdf
24. Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing HIV Infection. Geneva: World Health Organization; 2013. Available from: www.who.int/hiv/pub/guidelines/arv2013
25. WHO handbook for guideline development. Geneva: World Health Organization; 2012 [cited 2013 May 17]. Available from: http://www.who.int/kms/ guidelines-review-committee/en
26. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines. 3. Rating the quality of evidence introduction. J Clin Epidemiol. 2011;64:401-6.
27. Anglemyer AT, Rutherford GW, Easterbrook PJ, Horvath T, Vitoria M, Doherty M. Early initiation of antiretroviral therapy (ART) for individuals with HIV infection: a systematic review. Abstract no. TUPE 302. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Kuala Lumpur, Malaysia; 2013.
28. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. How should HIV programmes respond to evidence for the benefits of earlier treatment initiation? A combined analysis of twelve mathematical models. Lancet. 2013 Available from: http://www.hivmodelling.org.
29. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related millennium development goals: time for a public health approach. Lancet. 2011;378:282-4.
30. Rutherford GW, Anglemyer AT, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, et al. Predicting treatment failure (TF) in patients on antiretroviral therapy (ART): a systematic review of the performance characteristics of the 2010 World Health Organization (WHO) immunologic and clinical criteria for virologic failure. Abstract no. TUPE 269. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Kuala Lumpur, Malaysia; 2013.
31. Tucker JD, Bien C, Easterbrook PJ, Penazzato M, Doherty M, Victoria M, et al. Optimal monitoring strategies for HIV-infected individuals on antiretroviral therapy: a systematic review. Abstract no. WEPE 615. 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Kuala Lumpur, Malaysia; 2013.
32. Schwartlander B, Sotver J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/ AIDS. Lancet. 2011;377:2031-41.
33. Futures Institute [Internet]. Glastonbury, CT: Futures Institute; 2013 [cited 2013 May 15]. Available from: http://www.futuresinstitute.org